Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study
- PMID: 28892433
- DOI: 10.1200/JCO.2017.73.6728
Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study
Abstract
Purpose Previous US studies have shown that socioeconomic status (SES) affects survival in acute myeloid leukemia (AML). However, no large study has investigated the association between education or income and clinical characteristics, treatment, and outcome in AML. Methods To investigate the effects of education and income in a tax-supported health care system, we conducted a population-based study using individual-level SES and clinical data on all Danish patients with AML (2000 to 2014). We compared treatment intensity, allogeneic transplantation, and response rates by education and income level using logistic regression (odds ratios). We used Cox regression (hazard ratios [HRs]) to compare survival, adjusting for age, sex, SES, and clinical prognostic markers. Results Of 2,992 patients, 1,588 (53.1%) received intensive chemotherapy. Compared with low-education patients, highly educated patients more often received allogeneic transplantation (16.3% v 8.7%). In intensively treated patients younger than 60 years of age, increased mortality was observed in those with lower and medium education (1-year survival, 66.7%; adjusted HR, 1.47; 95% CI, 1.11 to 1.93; and 1-year survival, 67.6%; adjusted HR, 1.55; CI, 1.21 to 1.98, respectively) compared with higher education (1-year survival, 76.9%). Over the study period, 5-year survival improvements were limited to high-education patients (from 39% to 58%), increasing the survival gap between groups. In older patients, low-education patients received less intensive therapy (30% v 48%; adjusted odds ratio, 0.65; CI, 0.44 to 0.98) compared with high-education patients; however, remission rates and survival were not affected in those intensively treated. Income was not associated with therapy intensity, likelihood of complete remission, or survival (high income: adjusted HR, 1.0; medium income: adjusted HR, 0.96; 95% CI, 0.82 to 1.12; low income: adjusted HR, 1.06; CI, .88 to 1.27). Conclusion In a universal health care system, education level, but not income, affects transplantation rates and survival in younger patients with AML. Importantly, recent survival improvement has exclusively benefitted highly educated patients.
Similar articles
-
Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.Biol Blood Marrow Transplant. 2013 Jun;19(6):981-7. doi: 10.1016/j.bbmt.2013.03.016. Epub 2013 Apr 2. Biol Blood Marrow Transplant. 2013. PMID: 23562738
-
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.J Clin Oncol. 2015 Nov 1;33(31):3641-9. doi: 10.1200/JCO.2014.60.0890. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304885
-
Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.Asia Pac J Clin Oncol. 2014 Sep;10(3):246-54. doi: 10.1111/ajco.12188. Epub 2014 Mar 27. Asia Pac J Clin Oncol. 2014. PMID: 24673966
-
Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?Curr Opin Hematol. 2016 Mar;23(2):95-101. doi: 10.1097/MOH.0000000000000220. Curr Opin Hematol. 2016. PMID: 26825695 Review.
-
Explaining life course and cohort variation in the relationship between education and health: the role of income.J Health Soc Behav. 2006 Dec;47(4):324-38. doi: 10.1177/002214650604700402. J Health Soc Behav. 2006. PMID: 17240923 Review.
Cited by
-
American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.Blood Adv. 2020 Aug 11;4(15):3528-3549. doi: 10.1182/bloodadvances.2020001920. Blood Adv. 2020. PMID: 32761235 Free PMC article.
-
Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort study.Clin Epidemiol. 2019 Aug 28;11:769-780. doi: 10.2147/CLEP.S210456. eCollection 2019. Clin Epidemiol. 2019. PMID: 31695504 Free PMC article.
-
Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population-based cohort study.Hematol Oncol. 2022 Dec;40(5):1056-1066. doi: 10.1002/hon.3068. Epub 2022 Sep 6. Hematol Oncol. 2022. PMID: 35997314 Free PMC article.
-
One-Year Survival and Prognosticators of Adults With Acute Leukemia at the Uganda Cancer Institute.JCO Glob Oncol. 2023 Jul;9:e2200244. doi: 10.1200/GO.22.00244. JCO Glob Oncol. 2023. PMID: 37499182 Free PMC article.
-
Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms.JAMA Netw Open. 2024 Mar 4;7(3):e241112. doi: 10.1001/jamanetworkopen.2024.1112. JAMA Netw Open. 2024. PMID: 38436954 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous